Ivermectin: From theory to clinical application.

@article{Ashour2019IvermectinFT,
  title={Ivermectin: From theory to clinical application.},
  author={Dalia S. Ashour},
  journal={International journal of antimicrobial agents},
  year={2019}
}
  • D. Ashour
  • Published 7 May 2019
  • Medicine
  • International journal of antimicrobial agents
Approximately 250 million people have been using ivermectin (IVM) annually to combat many parasitic diseases including filariasis, onchocerciasis, strongyloidiasis, scabies and pediculosis. Many clinical studies have proven its efficacy against these diseases and have reported the optimum dose and duration of treatment. Moreover, its antiparasitic range has increased to cover more parasitic infections, but it still requires further exploration, e.g. for trichinosis and myiasis. Furthermore, IVM… Expand
Macrofilaricides: An Unmet Medical Need for Filarial Diseases.
TLDR
Recent approaches for targeting human filarial diseases are discussed including direct acting agents to target parasitic nematodes and anti-bacterial approaches to target the endosymbiotic bacteria, Wolbachia. Expand
Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication
TLDR
The collective review of recent efforts suggests that IVM has a prophylactic effect and would be a strong candidate for clinical trials to treat SARS-CoV-2. Expand
Ivermectin for preventing and treating COVID‐19
TLDR
To assess the efficacy and safety of ivermectin compared to no treatment, standard of care, placebo, or any other proven intervention for people with COVID-19 receiving treatment as inpatients or outpatients, and for prevention of an infection with SARS-CoV-2 (postexposure prophylaxis). Expand
Ivermectin, a potential anticancer drug derived from an antiparasitic drug
TLDR
The related mechanisms by which ivermectin inhibited the development of different cancers and promoted programmed cell death are reviewed and the prospects for the clinical application of iverMectin as an anticancer drug for neoplasm therapy are discussed. Expand
Ivermectin: An Anthelmintic, an Insecticide, and Much More.
Here we tell the story of ivermectin, describing its anthelmintic and insecticidal actions and recent studies that have sought to reposition ivermectin for the treatment of other diseases that areExpand
The Anthelmintic effect on Strongyloides venezuelensis induced by BnSP-6, a Lys49-phospholipase A2 homologue from Bothrops pauloensis venom.
TLDR
Light is shed on the potential of BnSP-6 as an anthelmintic agent, which can lead to further investigations as a tool for pharmaceutical discoveries. Expand
Heartworm disease – Overview, intervention, and industry perspective
TLDR
The objective of this review is to provide an overview of the disease, summarize the current disease control measures and highlight potential new avenues and best practices for treatment and prevention. Expand
Ivermectin: Potential Repurposing of a Versatile Antiparasitic as a Novel Anticancer
Drug repositioning is a alternative strategy to discover and develop anticancer drugs based on identification of new mechanisms of actions and indications for existing compounds. Ivermectin belongsExpand
Ivermectin and Moxidectin Can Incapacitate Different Strains of the Common Bed Bug Cimex lectularius L.: A Study
TLDR
A high-performance liquid chromatography and mass spectroscopy assay was developed and found that ivermectin persists in the insects for up to one month, which will be useful in understanding the pathophysiology behind the long-term morbidity observed in C. lectularius that consumes a sublethal dose of iverMectin. Expand
Marine Natural Products with Bioactivity Against Neglected Tropical Diseases
TLDR
A review of secondary metabolites isolated from marine sources that have demonstrated activity against neglected tropical diseases and are promising candidates for drug development discusses 114 marine derived metabolites active against the WHO's 2017 list of 20 NTDs. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 138 REFERENCES
Ivermectin in human medicine, an overview of the current status of its clinical applications.
TLDR
The use of ivermectin in human medicine has shown an outstanding low rate of adverse reactions, with the exception of treatment of loiasis and onchocerciasis, where the death of a high microfilarial load may cause severe encephalopathy. Expand
Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa
TLDR
The potential value of combination therapy with three currently approved drugs (ivermectin, DEC, and albendazole, or IDA) for advancing LF and onchocerciasis elimination programs in Africa is discussed. Expand
Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients.
TLDR
The basic pathogenic mechanisms that can be involved in the destruction of microfilaria by chemotherapeutic agents are reviewed and the possibility of genetic predispositions to pathology should also be considered. Expand
Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety
TLDR
This document examines the main pharmacokinetic and pharmacodynamic parameters of the medicine and their potential influence on its vector control efficacy and safety at population level. Expand
Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis.
TLDR
This review found that long-term reduction in the numbers of microfilaria in the skin and eyes and in the number of adult worms in the body has the potential to reduce the transmission and occurrence of onchocercal eye disease. Expand
Ivermectin lipid-based nanocarriers as novel formulations against head lice
TLDR
This investigation showed the effectiveness in the encapsulation of ivermectin (IVM) into stable LNC dispersion with a potential clinical activity against head lice. Expand
Combined ivermectin and doxycycline treatment has microfilaricidal and adulticidal activity against Dirofilaria immitis in experimentally infected dogs.
TLDR
Results indicate that the combination of these two drugs causes adult worm death, which could have important implications for control of human and animal filarial infections. Expand
Oral Ivermectin for Treatment of Pediculosis Capitis
TLDR
Ivermectin demonstrates high efficacy and tolerability in the treatment of pediculosis capitis in children, and a significant number of children required a second dose to ensure complete eradication. Expand
Determinants of parasite drug resistance in human lymphatic filariasis.
  • F. Cobo
  • Medicine
  • Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
  • 2016
TLDR
A review of the mechanisms of resistance to these antihelminthics is necessary in order to optimize the treatment for human lymphatic filariasis. Expand
Therapeutic efficacy of Dormectin, Ivermectin and Levamisole against different stages of Trichinella spiralis in rats.
TLDR
All of the tested drugs failed to inhibit the encysted larvae in the diaphragms of Trichinella spiralis infection in rats, reducing significantly the values of total proteins, and albumin while globulin, urea and creatinine values were significantly increased together with AST and ALT activities. Expand
...
1
2
3
4
5
...